Juniper Pharmaceuticals, Inc. Report issue

For profit Phase 2 Phase 3
Founded: Boston MA United States (1986)
Status: Acquired by Catalent (2018) → now Micron Technologies (2014)

Organization Overview

First Clinical Trial
2004
NCT00086177
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Columbia Laboratories | Columbia Laboratories, Inc | Columbia Laboratories, Inc. | VP Clinical Research; Columbia Laboratories, Inc

Active Ingredients

Drugs in Phase 3 Trials (1)

progesterone (progestasert) (4 trials)

Drugs in Phase 2 Trials (1)

lidocaine (xylocaine) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dysmenorrhea (Phase 2)

Premature Birth (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 2